1. Home
  2. HBIO

HBIO

Harvard Bioscience Inc.

Logo Harvard Bioscience Inc.

Industrials

Biotechnology: Laboratory Analytical Instruments

Nasdaq

as 04-12-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.

Founded: 1901 Country:
United States
United States
Employees: N/A City: HOLLISTON
Market Cap: 188.7M IPO Year: 2000
Target Price: $7.00 AVG Volume (30 days): 85.4K
Analyst Decision: Buy Number of Analysts: 2
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.08 EPS Growth: N/A
52 Week Low/High: $3.80 - $6.29 Next Earning Date: 04-23-2024
Revenue: $112,250,000 Revenue Growth: -0.96%
Revenue Growth (this year): 4.37% Revenue Growth (next year): 9.30%

Share on Social Networks: